Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.

Enhancing the endogenous capacity of myelin repair is a major therapeutic challenge in demyelinating diseases such as multiple sclerosis. We found that progesterone and the synthetic 19-norprogesterone derivative 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione (Nestorone) promote the remyelination of axons by oligodendrocytes after lysolecithin-induced demyelination in organotypic cultures of cerebellar slices taken from postnatal rats or mice. The intracellular progesterone receptors (PR) mediate the proremyelinating actions of Nestorone, because they are not observed in slices from PR knockout mice. Notably, Nestorone was less efficient in heterozygous mice, expressing reduced levels of PR, suggesting PR haploinsufficiency in myelin repair. Using mice expressing the enhanced green fluorescent protein (EGFP) under the control of the proteolipid gene promoter, we showed that both progesterone and Nestorone strongly increased the reappearance of cells of the oligodendroglial lineage in the demyelinated slices. In contrast to Nestorone, the pregnane derivative medroxyprogesterone acetate had no effect. The increase in oligodendroglial cells by Nestorone resulted from enhanced NG2(+) and Olig2(+) oligodendrocyte progenitor cell (OPC) recruitment. In cocultures of lysolecithin-demyelinated cerebellar slices from wild-type mice apposed to brain stem slices of proteolipid gene promoter-EGFP mice, Nestorone stimulated the migration of OPC towards demyelinated axons. In this coculture paradigm, Nestorone indeed markedly increased the number of EGFP(+) cells migrating into the demyelinated cerebellar slices. Our results show that Nestorone stimulates the recruitment and maturation of OPC, two steps which are limiting for efficient myelin repair. They may thus open new perspectives for the use of progestins, which selectively target PR, to promote the endogenous regeneration of myelin.

[1]  J. Manson,et al.  Update in hormone therapy use in menopause. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  R. Brinton,et al.  Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. , 2010, Endocrinology.

[3]  D. Wright,et al.  Progesterone in the clinical treatment of acute traumatic brain injury , 2010, Expert opinion on investigational drugs.

[4]  S. Ludwin,et al.  Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. , 2010, The American journal of pathology.

[5]  D. Chesik,et al.  Progesterone and dexamethasone differentially regulate the IGF-system in glial cells , 2010, Neuroscience Letters.

[6]  S. Vukusic,et al.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: Rationale, objectives and state of advancement , 2009, Journal of the Neurological Sciences.

[7]  M. Meyer,et al.  Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis , 2009, Brain Research.

[8]  Christina Wang,et al.  Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  M. Schumacher,et al.  Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury , 2009, Glia.

[10]  Z. Berente,et al.  17β‐estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice , 2009, Glia.

[11]  A. Chédotal,et al.  Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells , 2009, Annals of neurology.

[12]  Robin J. M. Franklin,et al.  Remyelination in the CNS: from biology to therapy , 2008, Nature Reviews Neuroscience.

[13]  R. Sitruk-Ware Reprint of Pharmacological profile of progestins , 2008 .

[14]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[15]  Richard F. Thompson,et al.  Progesterone receptors: Form and function in brain , 2008, Frontiers in Neuroendocrinology.

[16]  B. McEwen,et al.  Steroid hormone receptor expression and function in microglia , 2008, Glia.

[17]  D. Stein Progesterone exerts neuroprotective effects after brain injury , 2008, Brain Research Reviews.

[18]  L. Garay,et al.  Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  M. Schumacher,et al.  Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. , 2007, Endocrine reviews.

[20]  J. Dong,et al.  Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. , 2007, Endocrinology.

[21]  M. Simons,et al.  Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis , 2006, Journal of Cell Science.

[22]  V. Tawfik,et al.  Differential regulation of neuregulin 1 expression by progesterone in astrocytes and neurons. , 2006, Neuron glia biology.

[23]  David J. Anderson,et al.  Development of NG2 neural progenitor cells requires Olig gene function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Chao Zhao,et al.  Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system , 2006, Journal of neuroscience research.

[25]  R. Brinton,et al.  Medroxyprogesterone acetate exacerbates glutamate excitotoxicity , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[26]  M. Schumacher,et al.  Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures , 2005, Neuroscience.

[27]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[28]  D. Rowitch,et al.  bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS , 2004, Science.

[29]  J. Hapgood,et al.  Not all progestins are the same: implications for usage. , 2004, Trends in pharmacological sciences.

[30]  S. Fancy,et al.  Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS , 2004, Molecular and Cellular Neuroscience.

[31]  T. Rao,et al.  Lysolecithin induces demyelination in vitro in a cerebellar slice culture system , 2004, Journal of neuroscience research.

[32]  U. Suter,et al.  Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. , 2004, Brain : a journal of neurology.

[33]  J. Goldman,et al.  Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. , 2004, The American journal of pathology.

[34]  R. Sitruk-Ware Pharmacological profile of progestins. , 2004, Maturitas.

[35]  David Raban,et al.  Oligodendrocyte Progenitor Proliferation and Maturation Is Differentially Regulated by Male and Female Sex Steroid Hormones , 2004, Developmental Neuroscience.

[36]  M. Schumacher,et al.  Systemic progesterone administration results in a partial reversal of the age‐associated decline in CNS remyelination following toxin‐induced demyelination in male rats , 2004, Neuropathology and applied neurobiology.

[37]  R. Sitruk-Ware,et al.  Nestorone®: clinical applications for contraception and HRT , 2003, Steroids.

[38]  M. Schumacher,et al.  Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum , 2003, Journal of neurochemistry.

[39]  J. Li,et al.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. , 2002, Molecular endocrinology.

[40]  C. Brosnan,et al.  Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation , 2002, Nature Medicine.

[41]  Robert H Miller Regulation of oligodendrocyte development in the vertebrate CNS , 2002, Progress in Neurobiology.

[42]  G. Kidd,et al.  Proteolipid Promoter Activity Distinguishes Two Populations of NG2-Positive Cells throughout Neonatal Cortical Development , 2002, The Journal of Neuroscience.

[43]  K. Ukena,et al.  Effects of Progesterone Synthesized De Novo in the Developing Purkinje Cell on Its Dendritic Growth and Synaptogenesis , 2001, The Journal of Neuroscience.

[44]  N. Baumann,et al.  Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.

[45]  S. Koide,et al.  Nestorone®: a progestin with a unique pharmacological profile , 2000, Steroids.

[46]  M. Schumacher,et al.  Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord , 2000, Neuroscience Letters.

[47]  J. Chan,et al.  Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  B. O’Malley,et al.  Progesterone Receptor Function from a Behavioral Perspective , 1997, Hormones and Behavior.

[49]  M. Schumacher,et al.  Progesterone synthesis and myelin formation by Schwann cells. , 1995, Science.

[50]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[51]  R. Ahima,et al.  Postnatal development of corticosteroid receptor immunoreactivity in the rat cerebellum and brain stem. , 1992, Neuroendocrinology.

[52]  E. Baulieu,et al.  Estrogen-inducible progesterone receptor in primary cultures of rat glial cells. , 1991, Experimental cell research.

[53]  E. Baulieu,et al.  Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. , 1989, Endocrinology.

[54]  M. Schumacher,et al.  Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. , 2011, Maturitas.

[55]  Robert H Miller,et al.  Dissecting demyelination , 2007, Nature Neuroscience.

[56]  R. Brinton,et al.  Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. , 2002, Endocrinology.